These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9671257)

  • 1. The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme.
    Needham DM; Hogg RS; Yip B; O'Shaughnessy M; Schechter MT; Montaner JS
    Int J STD AIDS; 1998 Jun; 9(6):370-2. PubMed ID: 9671257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Impact of antiretroviral therapy in mortality of Chilean HIV (+) patients: a case control study].
    Wolff M; Bustamante C; Bidart T; Dabanch J; Diomedi A; Northland R
    Rev Med Chil; 2000 Aug; 128(8):839-45. PubMed ID: 11129544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
    Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective follow-up of a HIV infected population with and without access to antiretroviral therapy: impact of survival and complications].
    Wolff M; Diomedi A; Morales O; Bidart T; Dabanch J; Bustamante C; Northland R
    Rev Med Chil; 2001 Aug; 129(8):886-94. PubMed ID: 11680962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
    Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
    Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI; Sangeetha S; Earnest A; Bellamy R
    HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous evidence of fast HIV disease progression related to class-wide resistance to antiretroviral drugs: a 6 year follow-up analysis of a large observational database.
    Mauro Z; Federica F; Patrizia L; Francesca CS; Valerio T; Paola TM; Patrizia M; Pasquale N; Federico PC; Andrea A
    AIDS; 2007 Aug; 21(13):1824-6. PubMed ID: 17690586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-infected Rwandan women have a high frequency of long-term survival.
    Peters PJ; Karita E; Kayitenkore K; Meinzen-Derr J; Kim DJ; Tichacek A; Allen SA
    AIDS; 2007 Nov; 21 Suppl 6():S31-7. PubMed ID: 18032936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No protective effect of acyclovir on HIV disease progression in a cohort of HSV-2-HIV-infected individuals.
    Suligoi B; Dorrucci M; Volpi A; Andreoni M; Rezza G;
    Antivir Ther; 2002 Dec; 7(4):289-91. PubMed ID: 12553484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy.
    Fang CT; Chang YY; Hsu HM; Twu SJ; Chen KT; Lin CC; Huang LY; Chen MY; Hwang JS; Wang JD; Chuang CY
    QJM; 2007 Feb; 100(2):97-105. PubMed ID: 17277317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow.
    Fox R; Gourlay YJ
    Health Bull (Edinb); 2000 Jul; 58(4):309-15. PubMed ID: 12813810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.